Chronic hepatitis due to hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a major problem in terms of progressive liver damage, prevention and therapy in most parts of the world. Unfortunately, to date, there is still no specific and effective therapy for HBV. No therapy can be given to carrier, non- replicative and asymptomatic patients of chronic HBV infection. Lamivudine or alpha-interferon can be used for treatment of compensated, chronic hepatitis B infection with significant increase of aminotransferase. Approximately 40 % of patients can have seroconversion with this form of therapy. Chronic hepatitis D virus infection can be treat with alpha-interferon and in the final stage, may undergo liver transplantation. For chronic...
Chronic hepatitis B is still a major health problem in Indonesia. Unfortunately, to date, treatment ...
When assessing patients with chronic hepatitis B virus (HBV) infection, consider the state of viral ...
Primary hepatic lymphoma is a rare but well-defined lymphoma entity that often pursues an aggressive...
Chronic hepatitis due to hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a major problem...
Chronic hepatitis due to hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a major problem...
Chronic hepatitis due to hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a major problem...
Background: Nearly 14% of non-alcoholic chronic liver disease in India is related to hepatitis B vir...
Anaïs Vallet-Pichard and Pascal Lebray have equally participated in the preparation of the manuscrip...
This review updates the treatment of chronic hepatitis B infection. Complete eradication of hepatiti...
Patients with chronic hepatitis B virus (HBV) infection have a higher risk of developing liver cirrh...
Chronic hepatitis B virus (HBV) infection remains an important global burden with an estimated 240 m...
The available evidence on interferon-alpha (IFN) treatment for chronic hepatitis B is sufficient to ...
Treatment of chronic hepatitis B and C viruses (HBV and HCV) is still disappointing, and both are th...
The primary goal of therapy in patients with chronic hepatitis B is suppression and long-lasting mai...
More than 400 million people worldwide are chronically infected by the hepatitis B virus. The virus ...
Chronic hepatitis B is still a major health problem in Indonesia. Unfortunately, to date, treatment ...
When assessing patients with chronic hepatitis B virus (HBV) infection, consider the state of viral ...
Primary hepatic lymphoma is a rare but well-defined lymphoma entity that often pursues an aggressive...
Chronic hepatitis due to hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a major problem...
Chronic hepatitis due to hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a major problem...
Chronic hepatitis due to hepatitis B virus (HBV) or hepatitis C virus (HCV) is still a major problem...
Background: Nearly 14% of non-alcoholic chronic liver disease in India is related to hepatitis B vir...
Anaïs Vallet-Pichard and Pascal Lebray have equally participated in the preparation of the manuscrip...
This review updates the treatment of chronic hepatitis B infection. Complete eradication of hepatiti...
Patients with chronic hepatitis B virus (HBV) infection have a higher risk of developing liver cirrh...
Chronic hepatitis B virus (HBV) infection remains an important global burden with an estimated 240 m...
The available evidence on interferon-alpha (IFN) treatment for chronic hepatitis B is sufficient to ...
Treatment of chronic hepatitis B and C viruses (HBV and HCV) is still disappointing, and both are th...
The primary goal of therapy in patients with chronic hepatitis B is suppression and long-lasting mai...
More than 400 million people worldwide are chronically infected by the hepatitis B virus. The virus ...
Chronic hepatitis B is still a major health problem in Indonesia. Unfortunately, to date, treatment ...
When assessing patients with chronic hepatitis B virus (HBV) infection, consider the state of viral ...
Primary hepatic lymphoma is a rare but well-defined lymphoma entity that often pursues an aggressive...